Nanocapsule reaches cancer that has spread to central nervous system in mice

August 14, 2019

FINDINGS

Cancer that has spread to the central nervous system is notoriously difficult to treat. Now, UCLA researchers have developed a drug delivery system that breaks through the blood-brain barrier in order to reach and treat cancer that has spread to the central nervous system.

In research conducted in mice, a single dose of cancer drugs in a nanoscale capsule developed by the scientists eliminated all B-cell lymphoma that had metastasized to the animals' central nervous system.

BACKGROUND

About 15% to 40% of all cancers spread to the nervous system, but there are few treatment options and they only work in a small number of patients. One reason treatments are ineffective is that the blood-brain barrier, a natural defense system that prevents harmful agents from entering the brain, blocks many drugs, preventing them from reaching cancer that has spread to the central nervous system.

METHOD

To create a vessel that could carry cancer drugs to the central nervous system, the scientists produced a capsule measuring about one nanometer, or one billionth of a meter, across. (For reference, a sheet of paper is about 100,000 nanometers thick.) The capsule is coated with a substance called 2-methacryloyloxyethyl phosphorylcholine, which they hypothesized would be unlikely to be blocked by the blood-brain barrier, which would enable the capsule to release antibodies when it came into close proximity with cancerous cells.

The researchers loaded nanocapsules with the cancer-fighting drug rituximab and then administered them to mice with a human B-cell lymphoma that had metastasized to the animals' central nervous system. The scientists tracked how the tumors grew or shrank over a period of four months.

IMPACT

Pending additional research, including testing in human subjects, the UCLA-engineered capsule could be used to carry drugs that have already been approved by the FDA to treat cancer that has spread to the central nervous system.

The approach could be useful not only for cancers that metastasize to the central nervous system -- such as breast cancer, small cell lung cancer and melanoma -- but also for primary brain tumors or other brain diseases.
-end-
AUTHORS

The study's senior author is Masakazu Kamata, an associate professor of hematology/oncology at the David Geffen School of Medicine at UCLA and scientist at the UCLA Jonsson Comprehensive Cancer.

Other authors are Jing Wen, Di Wu, Meng Qin, Chaoyong Liu, Lan Wang, Duo Xu, Harry Vinters, Yang Liu, Emiko Kranz, YooJin Lee, Ontoniel Martinez-Maza, Daniel Widney, Irvin Chen and Yunfeng Lu, all of UCLA.

JOURNAL

The study is published online in Nature Biomedical Engineering.

FUNDING

The study was funded by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and the McCarthy Family Foundation.

University of California - Los Angeles Health Sciences

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.